NCT01242488 2024-07-17Efficacy and Safety of CDP6038 in Patients With Rheumatoid Arthritis With an Unsuccessful Response to Anti-Tumor Necrosis Factor (Anti-TNF) TherapyUCB PharmaPhase 2 Completed221 enrolled
NCT01463059 2013-03-25Efficacy and Safety of Olokizumab With Rheumatoid Arthritis With Previously Failed to Anti-tumor Necrosis Factor (Anti-TNF) TherapyUCB PharmaPhase 2 Completed119 enrolled